ArticleThe Permanente journal2023

Safety and Efficacy of Intramuscular Tixagevimab-Cilgavimab in Prevention of COVID-19 in Patients Who Are Immunocompromised.

Rebecca Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.